Benefit-based interventions to address chronic disease compliance generally involve one of two approaches. The most common strategy is to exempt classes of drugs from copayments or coinsurance; a less tested strategy is to exempt classes of patients (i.e., diabetics) from cost sharing. Do such interventions improve health outcomes, and do they save money?
A research report showing that the proposed California paid sick days legislation will have significant positive public health impacts.
This report provides a review of the literature on the public health impacts of paid sick leave. To date, research in this area has been somewhat limited. Generally speaking, the literature focuses on a few key industries and illnesses. These include the commercial food, health-services and child-care industries, and common illnesses such as gastrointestinal and respiratory infections.
Health care proposals should take into account what Californians currently spend on health care. As this analysis reveals, health care currently represents a significant expense for lower and middle income workers (families with incomes less than 300% of FPL), especially if they purchase coverage through the individual market.